Theriva Biologics, Inc. (TOVX)
Theriva Biologics, Inc. (TOVX) is a biotechnology company focused on the development of targeted therapies for cancer and other diseases. The company specializes in the design and engineering of oncolytic viruses and other biologic treatments to improve safety and efficacy in cancer therapy. Based in the United States, Theriva aims to advance innovative solutions through its proprietary platforms and collaborations.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| January 10, 2008 | $0.05 | 2007-12-27 | 2007-12-31 |
Dividends Summary
- Theriva Biologics, Inc. has issued 1 dividend payments over the past 0 years
- The most recent dividend was paid 6463 days ago, on January 10, 2008
- The highest dividend payed out to investors during this period was $0.0475 per share
- The average dividend paid during this period was $0.05 per share.
Company News
Theriva Biologics announced positive Phase 2b VIRAGE trial results for VCN-01 in metastatic pancreatic cancer, with improved overall survival and progression-free survival. The company is preparing for a potential Phase 3 trial and presented retinoblastoma study data at ASCO 2025.
US stock futures are trading higher ahead of a shortened trading session on Christmas Eve. Analysts expect a 'Santa Rally' during this period, which has historically seen positive returns. However, they also caution about potential market corrections in 2025 due to stretched valuations.